Sincrolab is an AI-based training solution focused on the recovery and development of cognitive abilities.
Play Video
Sincrolab is a personalized stimulation system, adaptive and scientifically validated.
Sincrolab is a personalized, adaptive, and scientifically validated stimulation system.
Sincrolab helped 73% of patients with ADHD achieve cognitive improvements in inhibitory control.
In the first Spanish placebo-controlled trial of a digital therapy, Sincrolab proved to be significantly more effective than the placebo. Moreover, after twelve weeks, 54% of Sincrolab patients achieved a clinically significant improvement in inhibitory control.
Some of the centers that have already integrated Sincrolab into their cognitive stimulation therapy:
With whom we collaborate
Sincrolab collaborates with numerous important companies, both nationally and internationally, that have supported the project from the beginning:
Some centers share with us
how Sincrolab has helped them improve therapies for children with ADHD
"We firmly believe that this platform has a lot of potential, and for us, it has meant a radical change in patient management (especially in terms of monitoring progress and initial therapeutic approach). The use of computerized treatment in children with an ADHD diagnosis or suspected diagnosis is useful and improves their core symptoms. Being a computerized treatment, we find it quick and convenient for administration. It allows for the collection of relevant, more precise, and objective clinical information for clinical decision-making."